The Health Resources and Services Administration threatens sanctions against Johnson & Johnson over the company’s decision to change how hospitals are provided 340B discounts on some prescription drugs. And, a summer surge of COVID infections could be abating...We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare podcast.
Hosted on Acast. See acast.com/privacy for more information.
